<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02451670</url>
  </required_header>
  <id_info>
    <org_study_id>A13-154</org_study_id>
    <secondary_id>U19MH092201</secondary_id>
    <nct_id>NCT02451670</nct_id>
  </id_info>
  <brief_title>Reducing Cardiovascular Risk in Adults With Serious Mental Illness</brief_title>
  <acronym>SMIWizard</acronym>
  <official_title>Reducing Cardiovascular Risk in Adults With Serious Mental Illness Using an Electronic Medical Record-based Clinical Decision Support</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HealthPartners Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Essentia Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Park Nicollet Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>HealthPartners Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project will test the ability of an electronic medical record-based clinical decision
      support system to help primary care providers identify, provide more appropriate care for,
      and control Cardiovascular risk factors for patients with Serious Mental Illness.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This proposal will adapt a point-of-care Electronic Medical Record-based Clinical Decision
      Support system (Cardiovascular Wizard) to help primary care providers identify, provide
      appropriate care for, and control Cardiovascular risk factors for patients with Serious
      Mental Illness. Cardiovascular Wizard is designed to educate Primary Care Providers about the
      increased risk of cardiovascular disease and mortality in people with serious mental illness,
      identify elevated cardiovascular risk factors in patients with serious mental illness,
      prioritize these cardiovascular risks based on how much improvement in cardiovascular risk a
      patient would experience if the cardiovascular risk factor was adequately addressed,
      recommend specific medications and other interventions to decrease each elevated
      cardiovascular risk factor, and provide this information in an easy-to-understand format for
      both patients with serious mental illness and their primary care providers. For those
      patients who are on the serious mental illness medications most associated with weight gain,
      they will be able to work with a psychiatric care manager who, under the supervision of the
      patient's treating psychiatrist and with the consent of the patient, will switch the serious
      mental illness medication to one less associated with weight gain.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Clinics have been randomized into a treatment and a control arm.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduced total Cardiovascular modifiable risk level evaluated using the Framingham ten year cardiovascular disease risk equation</measure>
    <time_frame>Participants will be followed for a minimum of 12 months post index</time_frame>
    <description>The Framingham ten year cardiovascular Disease Risk Equation will be used to estimate the ten year cardiovascular risk for each adult patient with serious mental illness and calculated every time a constituent modifiable risk factor is recorded in the electronic medical record during the intervention period. At each encounter, we will extract from the electronic medical record the most recent data elements for computing cardiovascular risk, looking back over a period appropriate for each risk component.The series of cardiovascular risk scores will enable person-specific cardiovascular risk trajectories to be estimated and compared among patients treated in cardiovascular Wizard clinics relative to control clinics. A comparison of model-predicted twelve month post-index cardiovascular risk scores demonstrating lower modifiable cardiovascular risk in patients in the cardiovascular Wizard relative to control clinics will support the primary efficacy of the hypothesis .</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2250</enrollment>
  <condition>Chronic Disease</condition>
  <condition>Mental Disorder</condition>
  <condition>Health Behavior</condition>
  <condition>Bipolar Disorder</condition>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in the usual care arm of the study do not receive the Wizard patient and provider display which prompts cardiovascular reduction discussion during a primary care visit, and do not receive a study-initiated assessment regarding high Body Mass Index and obesogenic medication.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wizard algorithm risk reduction advice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the intervention arm of the study who meet study criteria (a qualifying serious mental illness and not at goal for any of the six cardiovascular risk areas) will receive Wizard algorithm individual-specific written and verbal advice as to prioritized treatment and lifestyle changes, prompted by an Electronic Medical Record based alert and printed display of risks, during their primary care visit. The patients who have a high Body Mass Index and are on an obesogenic medication will also be contacted for a possible change in medication to a less-obesogenic medication, if appropriate.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Wizard algorithm risk reduction advice</intervention_name>
    <description>Wizard algorithm risk reduction advice is made available by web-based Clinical Decision Support algorithms estimate the patient's cardiovascular risk and quantify decreases in cardiovascular risk with appropriate management of out-of-control cardiovascular risk factors. The algorithms identify evidence-based treatment options to address each uncontrolled cardiovascular risk factor. Lifestyle treatment recommendations are also provided, when appropriate.</description>
    <arm_group_label>Wizard algorithm risk reduction advice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Serious Mental Illness diagnosis

          -  age 18-75

          -  not in hospice

          -  not at goal for at least one of the six cardiovascular risk factor areas

        Exclusion Criteria:

          -  No Serious Mental Illness diagnosis

          -  under age 18 or over age 75

          -  in hospice

          -  at goal for all 6 areas
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca C Rossom, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HealthPartners Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Essentia Health</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Park Nicollet Clinic</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HealthPartners</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry. 2011 Feb;23(1):40-7. Review.</citation>
    <PMID>21318195</PMID>
  </reference>
  <reference>
    <citation>Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database. Arch Gen Psychiatry. 2007 Feb;64(2):242-9. Erratum in: Arch Gen Psychiatry. 2007 Jun;64(6):736.</citation>
    <PMID>17283292</PMID>
  </reference>
  <reference>
    <citation>De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Möller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 2009 Sep;24(6):412-24. doi: 10.1016/j.eurpsy.2009.01.005. Epub 2009 Aug 13.</citation>
    <PMID>19682863</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Crain AL, Rush WA, Sperl-Hillen JM, Gutenkauf JJ, Duncan JE. Impact of an electronic medical record on diabetes quality of care. Ann Fam Med. 2005 Jul-Aug;3(4):300-6.</citation>
    <PMID>16046561</PMID>
  </reference>
  <reference>
    <citation>Osby U, Correia N, Brandt L, Ekbom A, Sparén P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res. 2000 Sep 29;45(1-2):21-8.</citation>
    <PMID>10978869</PMID>
  </reference>
  <reference>
    <citation>Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005 Dec;150(6):1115-21. Review.</citation>
    <PMID>16338246</PMID>
  </reference>
  <reference>
    <citation>Dixon L, Postrado L, Delahanty J, Fischer PJ, Lehman A. The association of medical comorbidity in schizophrenia with poor physical and mental health. J Nerv Ment Dis. 1999 Aug;187(8):496-502.</citation>
    <PMID>10463067</PMID>
  </reference>
  <reference>
    <citation>Davidson S, Judd F, Jolley D, Hocking B, Thompson S, Hyland B. Cardiovascular risk factors for people with mental illness. Aust N Z J Psychiatry. 2001 Apr;35(2):196-202.</citation>
    <PMID>11284901</PMID>
  </reference>
  <reference>
    <citation>Druss BG, Bradford WD, Rosenheck RA, Radford MJ, Krumholz HM. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry. 2001 Jun;58(6):565-72.</citation>
    <PMID>11386985</PMID>
  </reference>
  <reference>
    <citation>Trangle M, Gary M, Paul G, Christensen R. Minnesota 10 by 10. Reducing morbidity and mortality in people with serious mental illnesses. Minn Med. 2010 Jun;93(6):38-41.</citation>
    <PMID>20827954</PMID>
  </reference>
  <reference>
    <citation>Goff DC, Sullivan LM, McEvoy JP, Meyer JM, Nasrallah HA, Daumit GL, Lamberti S, D'Agostino RB, Stroup TS, Davis S, Lieberman JA. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005 Dec 1;80(1):45-53. Epub 2005 Sep 28.</citation>
    <PMID>16198088</PMID>
  </reference>
  <reference>
    <citation>Newcomer JW. Medical risk in patients with bipolar disorder and schizophrenia. J Clin Psychiatry. 2006;67 Suppl 9:25-30; discussion 36-42. Review.</citation>
    <PMID>16965186</PMID>
  </reference>
  <reference>
    <citation>Kilbourne AM, Cornelius JR, Han X, Pincus HA, Shad M, Salloum I, Conigliaro J, Haas GL. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004 Oct;6(5):368-73.</citation>
    <PMID>15383128</PMID>
  </reference>
  <reference>
    <citation>Birkenaes AB, Opjordsmoen S, Brunborg C, Engh JA, Jonsdottir H, Ringen PA, Simonsen C, Vaskinn A, Birkeland KI, Friis S, Sundet K, Andreassen OA. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry. 2007 Jun;68(6):917-23.</citation>
    <PMID>17592917</PMID>
  </reference>
  <reference>
    <citation>Wong CK, Tang EW, Herbison P, Birmingham B, Barclay L, Fu SY. Pre-existent depression in the 2 weeks before an acute coronary syndrome can be associated with delayed presentation of the heart attack. QJM. 2008 Feb;101(2):137-44. doi: 10.1093/qjmed/hcm153. Epub 2008 Jan 10.</citation>
    <PMID>18187481</PMID>
  </reference>
  <reference>
    <citation>Druss BG. Improving medical care for persons with serious mental illness: challenges and solutions. J Clin Psychiatry. 2007;68 Suppl 4:40-4.</citation>
    <PMID>17539699</PMID>
  </reference>
  <reference>
    <citation>Laursen TM, Munk-Olsen T, Agerbo E, Gasse C, Mortensen PB. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry. 2009 Jul;66(7):713-20. doi: 10.1001/archgenpsychiatry.2009.61.</citation>
    <PMID>19581562</PMID>
  </reference>
  <reference>
    <citation>Mackin P, Bishop DR, Watkinson HM. A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients. BMC Psychiatry. 2007 Jun 25;7:28.</citation>
    <PMID>17592636</PMID>
  </reference>
  <reference>
    <citation>Shah SU, White A, White S, Littler WA. Heart and mind: (1) relationship between cardiovascular and psychiatric conditions. Postgrad Med J. 2004 Dec;80(950):683-9. Review.</citation>
    <PMID>15579605</PMID>
  </reference>
  <reference>
    <citation>Sowden GL, Huffman JC. The impact of mental illness on cardiac outcomes: a review for the cardiologist. Int J Cardiol. 2009 Feb 6;132(1):30-7. doi: 10.1016/j.ijcard.2008.10.002. Epub 2008 Nov 11. Review.</citation>
    <PMID>19004512</PMID>
  </reference>
  <reference>
    <citation>Taylor V, MacQueen G. Associations between bipolar disorder and metabolic syndrome: A review. J Clin Psychiatry. 2006 Jul;67(7):1034-41. Review.</citation>
    <PMID>16889445</PMID>
  </reference>
  <reference>
    <citation>Klumpers UM, Boom K, Janssen FM, Tulen JH, Loonen AJ. Cardiovascular risk factors in outpatients with bipolar disorder. Pharmacopsychiatry. 2004 Sep;37(5):211-6.</citation>
    <PMID>15470799</PMID>
  </reference>
  <reference>
    <citation>American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004 Feb;27(2):596-601. Review.</citation>
    <PMID>14747245</PMID>
  </reference>
  <reference>
    <citation>Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA. 2000 Jan 26;283(4):506-11.</citation>
    <PMID>10659877</PMID>
  </reference>
  <reference>
    <citation>Frayne SM, Halanych JH, Miller DR, Wang F, Lin H, Pogach L, Sharkansky EJ, Keane TM, Skinner KM, Rosen CS, Berlowitz DR. Disparities in diabetes care: impact of mental illness. Arch Intern Med. 2005 Dec 12-26;165(22):2631-8.</citation>
    <PMID>16344421</PMID>
  </reference>
  <reference>
    <citation>Desai MM, Rosenheck RA, Druss BG, Perlin JB. Mental disorders and quality of diabetes care in the veterans health administration. Am J Psychiatry. 2002 Sep;159(9):1584-90.</citation>
    <PMID>12202281</PMID>
  </reference>
  <reference>
    <citation>Fagiolini A, Chengappa KN, Soreca I, Chang J. Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden. CNS Drugs. 2008;22(8):655-69. Review.</citation>
    <PMID>18601304</PMID>
  </reference>
  <reference>
    <citation>Mitchell JE, Mackenzie TB. Cardiac effects of lithium therapy in man: a review. J Clin Psychiatry. 1982 Feb;43(2):47-51.</citation>
    <PMID>7056703</PMID>
  </reference>
  <reference>
    <citation>Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry. 2001 Nov;158(11):1774-82. Review.</citation>
    <PMID>11691681</PMID>
  </reference>
  <reference>
    <citation>Morriss R, Mohammed FA. Metabolism, lifestyle and bipolar affective disorder. J Psychopharmacol. 2005 Nov;19(6 Suppl):94-101. Review.</citation>
    <PMID>16280342</PMID>
  </reference>
  <reference>
    <citation>Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002 Apr;68(2-3):167-81.</citation>
    <PMID>12063145</PMID>
  </reference>
  <reference>
    <citation>Ryan MC, Thakore JH. Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci. 2002 Jun 7;71(3):239-57. Review.</citation>
    <PMID>12034344</PMID>
  </reference>
  <reference>
    <citation>Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005 Sep 22;353(12):1209-23. Epub 2005 Sep 19. Erratum in: N Engl J Med. 2010 Sep 9;363(11):1092-3.</citation>
    <PMID>16172203</PMID>
  </reference>
  <reference>
    <citation>Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, Lin PH, Champagne C, Harsha DW, Svetkey LP, Ard J, Brantley PJ, Proschan MA, Erlinger TP, Appel LJ; PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med. 2006 Apr 4;144(7):485-95.</citation>
    <PMID>16585662</PMID>
  </reference>
  <reference>
    <citation>Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998 Mar 18;279(11):839-46. Erratum in: JAMA 1998 Jun 24;279(24):1954.</citation>
    <PMID>9515998</PMID>
  </reference>
  <reference>
    <citation>Daumit GL, Dickerson FB, Wang NY, Dalcin A, Jerome GJ, Anderson CA, Young DR, Frick KD, Yu A, Gennusa JV 3rd, Oefinger M, Crum RM, Charleston J, Casagrande SS, Guallar E, Goldberg RW, Campbell LM, Appel LJ. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med. 2013 Apr 25;368(17):1594-602. doi: 10.1056/NEJMoa1214530. Epub 2013 Mar 21.</citation>
    <PMID>23517118</PMID>
  </reference>
  <reference>
    <citation>Pylvänen V, Knip M, Pakarinen A, Kotila M, Turkka J, Isojärvi JI. Serum insulin and leptin levels in valproate-associated obesity. Epilepsia. 2002 May;43(5):514-7.</citation>
    <PMID>12027912</PMID>
  </reference>
  <reference>
    <citation>Sachs G, Bowden C, Calabrese JR, Ketter T, Thompson T, White R, Bentley B. Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. Bipolar Disord. 2006 Apr;8(2):175-81.</citation>
    <PMID>16542188</PMID>
  </reference>
  <reference>
    <citation>Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry. 1999 Nov;156(11):1686-96. Review.</citation>
    <PMID>10553730</PMID>
  </reference>
  <reference>
    <citation>Komossa K, Rummel-Kluge C, Schmid F, Hunger H, Schwarz S, El-Sayeh HG, Kissling W, Leucht S. Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006569. doi: 10.1002/14651858.CD006569.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD006569.</citation>
    <PMID>19821375</PMID>
  </reference>
  <reference>
    <citation>Patel JK, Buckley PF, Woolson S, Hamer RM, McEvoy JP, Perkins DO, Lieberman JA; CAFE Investigators. Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study. Schizophr Res. 2009 Jun;111(1-3):9-16. doi: 10.1016/j.schres.2009.03.025. Epub 2009 Apr 26.</citation>
    <PMID>19398192</PMID>
  </reference>
  <reference>
    <citation>Sittig DF, Wright A, Osheroff JA, Middleton B, Teich JM, Ash JS, Campbell E, Bates DW. Grand challenges in clinical decision support. J Biomed Inform. 2008 Apr;41(2):387-92. Epub 2007 Sep 21. Review.</citation>
    <PMID>18029232</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Sperl-Hillen JM, Rush WA, Johnson PE, Amundson GH, Asche SE, Ekstrom HL, Gilmer TP. Impact of electronic health record clinical decision support on diabetes care: a randomized trial. Ann Fam Med. 2011 Jan-Feb;9(1):12-21. doi: 10.1370/afm.1196.</citation>
    <PMID>21242556</PMID>
  </reference>
  <reference>
    <citation>Leibson C, Owens T, O'Brien P, Waring S, Tangalos E, Hanson V, Plevak M, Kokmen E. Use of physician and acute care services by persons with and without Alzheimer's disease: a population-based comparison. J Am Geriatr Soc. 1999 Jul;47(7):864-9.</citation>
    <PMID>10404933</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Desai JR, Butler JC, Kharbanda EO, Sperl-Hillen JM. Current status and future prospects for electronic point-of-care clinical decision support in diabetes care. Curr Diab Rep. 2013 Apr;13(2):172-6. doi: 10.1007/s11892-012-0350-z.</citation>
    <PMID>23225213</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Quiter ES, Rush WA, Wiest M, Meland JT, Ryu S. Impact of hypertension guideline implementation on blood pressure control and drug use in primary care clinics. Jt Comm J Qual Improv. 1999 Feb;25(2):68-77.</citation>
    <PMID>10027112</PMID>
  </reference>
  <reference>
    <citation>Boyle RG, O'Connor PJ, Pronk NP, Tan A. Stages of change for physical activity, diet, and smoking among HMO members with chronic conditions. Am J Health Promot. 1998 Jan-Feb;12(3):170-5.</citation>
    <PMID>10176091</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Asche SE, Crain AL, Rush WA, Whitebird RR, Solberg LI, Sperl-Hillen JM. Is patient readiness to change a predictor of improved glycemic control? Diabetes Care. 2004 Oct;27(10):2325-9.</citation>
    <PMID>15451895</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Sperl-Hillen J. Clinical and public health implications of glycemic relapse in type 2 diabetes. Nat Clin Pract Endocrinol Metab. 2007 Jan;3(1):10-1.</citation>
    <PMID>17179924</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Rush WA, Prochaska JO, Pronk NP, Boyle RG. Professional advice and readiness to change behavioral risk factors among members of a managed care organization. Am J Manag Care. 2001 Feb;7(2):125-30.</citation>
    <PMID>11216330</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ. Electronic medical records and diabetes care improvement: are we waiting for Godot? Diabetes Care. 2003 Mar;26(3):942-3. Review.</citation>
    <PMID>12610062</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2015</study_first_submitted>
  <study_first_submitted_qc>May 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 22, 2015</study_first_posted>
  <last_update_submitted>December 11, 2017</last_update_submitted>
  <last_update_submitted_qc>December 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

